Background and Purpose: Adhesive capsulitis, or frozen
shoulder, leads to pain and reduced mobility due to joint inflammation and
fibrosis. While physiotherapy is the standard treatment, recovery is often a
slow process. Platelet-rich plasma (PRP), rich in growth factors, may enhance
healing. This study aims to evaluate the effectiveness of Platelet-Rich Plasma
in combination with physiotherapy on biomarkers, soft tissue morphology, and
function in patients with shoulder adhesive capsulitis.
Methods: From June to December 2025, a double-blinded
randomized control trial will be conducted at Jashore University of Science and
Technology, Bangladesh, enrolling 60 patients with shoulder adhesive
capsulitis. Participants will be randomly assigned to either PRP with
physiotherapy (experimental) or sham PRP with physiotherapy (control),
receiving 24 therapy sessions over 6 weeks. Primary outcomes include pain
sensitivity, blood cell counts from synovial fluid, and soft tissue morphology.
The secondary outcome is functional ability measured by Shoulder Pain and
Disability Index (SPADI) at multiple time points. Ethical approval and trial
registration will be obtained, and ICH-GCP guidelines will be followed. All
adverse effects will be monitored and reported.
Discussion: The findings from this trial
will highlight the synergistic effects of platelet-rich plasma (PRP) and
physiotherapy in managing adhesive capsulitis. By addressing both the
biological and mechanical contributors to the condition, the combined
intervention could offer greater improvements in pain modulation, soft-tissue
restoration, and functional outcomes compared to physiotherapy alone. Notably,
changes in blood biomarkers and soft-tissue morphology may provide deeper
insight into the therapeutic mechanisms of PRP. These results could inform
future integrative rehabilitation protocols and support more personalized
approaches to frozen shoulder management. However, long-term effects,
cost-effectiveness, and broader applicability should be explored in future
studies.
Conclusion: This study will provide
essential evidence on the effectiveness of PRP therapy in evaluating muscle
morphology and improving functional recovery in patients with adhesive
capsulitis. The findings will contribute to advancing diagnostic accuracy,
optimizing treatment strategies, and enhancing future research in musculoskeletal
rehabilitation.Background and Purpose: Adhesive capsulitis, or frozen
shoulder, leads to pain and reduced mobility due to joint inflammation and
fibrosis. While physiotherapy is the standard treatment, recovery is often a
slow process. Platelet-rich plasma (PRP), rich in growth factors, may enhance
healing. This study aims to evaluate the effectiveness of Platelet-Rich Plasma
in combination with physiotherapy on biomarkers, soft tissue morphology, and
function in patients with shoulder adhesive capsulitis.
Methods: From June to December 2025, a double-blinded
randomized control trial will be conducted at Jashore University of Science and
Technology, Bangladesh, enrolling 60 patients with shoulder adhesive
capsulitis. Participants will be randomly assigned to either PRP with
physiotherapy (experimental) or sham PRP with physiotherapy (control),
receiving 24 therapy sessions over 6 weeks. Primary outcomes include pain
sensitivity, blood cell counts from synovial fluid, and soft tissue morphology.
The secondary outcome is functional ability measured by Shoulder Pain and
Disability Index (SPADI) at multiple time points. Ethical approval and trial
registration will be obtained, and ICH-GCP guidelines will be followed. All
adverse effects will be monitored and reported.
Discussion: The findings from this trial
will highlight the synergistic effects of platelet-rich plasma (PRP) and
physiotherapy in managing adhesive capsulitis. By addressing both the
biological and mechanical contributors to the condition, the combined
intervention could offer greater improvements in pain modulation, soft-tissue
restoration, and functional outcomes compared to physiotherapy alone. Notably,
changes in blood biomarkers and soft-tissue morphology may provide deeper
insight into the therapeutic mechanisms of PRP. These results could inform
future integrative rehabilitation protocols and support more personalized
approaches to frozen shoulder management. However, long-term effects,
cost-effectiveness, and broader applicability should be explored in future
studies.
Conclusion: This study will provide
essential evidence on the effectiveness of PRP therapy in evaluating muscle
morphology and improving functional recovery in patients with adhesive
capsulitis. The findings will contribute to advancing diagnostic accuracy,
optimizing treatment strategies, and enhancing future research in musculoskeletal
rehabilitation.